...
首页> 外文期刊>In vivo. >Perioperative Management in Patients With Undergoing Direct Oral Anticoagulant Therapy in Oral Surgery – A Multicentric Questionnaire Survey
【24h】

Perioperative Management in Patients With Undergoing Direct Oral Anticoagulant Therapy in Oral Surgery – A Multicentric Questionnaire Survey

机译:在口腔外科手术中接受直接口服抗凝治疗的患者的围手术期管理–多中心问卷调查

获取原文
           

摘要

Aim: The purpose of this study was to survey the current opinions of hospitals and medical practices concerning the perioperative management of patients undergoing direct oral anticoagulant therapy (DOAC) and discuss recommendations for the clinical practice. Materials and Methods: A questionnaire with 13 topics and multiple ordinal-polytomous subitems was designed and sent to 120 Departments of Oral and Maxillofacial Surgery in Austria, Switzerland and Germany, as well as to 85 oral and maxillofacial/oral surgeons in medical offices in Hamburg, Germany. The data were statistically evaluated by Chi-square, Fisher's exact and Jonckheere-Terpstra tests. Results: The rate of response was 42%. Thirty-seven percent of respondents reported treating over 50 patients per year with undergoing DOAC therapy and only 18% assess a high bleeding risk [33% for vitamin K antagonists (VKA)]. In contrast to that, 62% of respondents would interrupt the DOAC therapy for extraction of one tooth, while 94% would continue VKA therapy. Significantly more clinicians apply suture than those in a medical office. The use of additional hemostatic measures varied between clinic and medical practice. There was a clear request for more detailed guidelines. Conclusion: The study shows the current opinion for perioperative management of patients undergoing DOAC therapy. Multi-centric studies under controlled conditions are needed for a safer treatment of anticoagulated patients as therapy strategies differ greatly between institutions and therefore a complication analysis is hardly possible.
机译:目的:本研究旨在调查医院和医疗实践对接受直接口服抗凝治疗(DOAC)的患者围手术期管理的当前观点,并讨论有关临床实践的建议。材料和方法:设计了一个包含13个主题和多个序贯多子项的问卷,并发送给了奥地利,瑞士和德国的120个口腔颌面外科部门以及汉堡医疗办公室的85个口腔颌面外科医师,德国。通过卡方检验,Fisher精确检验和Jonckheere-Terpstra检验对数据进行统计学评估。结果:回应率为42%。 37%的受访者报告说每年接受DOAC治疗的患者超过50名,只有18%的人有较高的出血风险[33%的维生素K拮抗剂(VKA)]。与此相反,有62%的受访者会中断DOAC治疗以拔除一颗牙齿,而94%的受访者会继续进行VKA治疗。与医疗办公室相比,使用缝合线的临床医生明显更多。在临床和医学实践之间,对其他止血措施的使用也有所不同。明确要求提供更详细的指南。结论:该研究显示了对接受DOAC治疗的患者围手术期治疗的最新观点。由于各机构之间的治疗策略差异很大,因此需要在可控条件下进行多中心研究,以更安全地治疗抗凝患者,因此很难进行并发症分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号